A novel compound heterozygous mutation in SLC5A2 contributes to familial renal glucosuria in a Chinese family, and a review of the relevant literature

Mol Med Rep. 2019 May;19(5):4364-4376. doi: 10.3892/mmr.2019.10110. Epub 2019 Apr 1.

Abstract

Familial renal glucosuria (FRG) is a rare condition that involves isolated glucosuria despite normal blood glucose levels. Mutations in the solute carrier family 5 member 2 (SLC5A2) gene, which encodes sodium‑glucose cotransporter 2 (SGLT2), have been reported to be responsible for the disease. Genetic testing of the SLC5A2 gene was conducted in a Chinese family with FRG. A number of online tools were used to predict the potential effect of the identified mutations on SGLT2 function. Additionally, the SLC5A2 mutations previously reported in PubMed were summarized. A novel compound heterozygous mutation (c.514T>C, p.W172R; c.1540C>T, p.P514S) of the SLC5A2 gene in a Chinese child with FRG was identified. In total, 86 mutations of the SLC5A2 gene have been reported to be associated with FRG. The novel compound heterozygous mutation (c.514T>C, p.W172R; c.1540C>T, p.P514S) of the SLC5A2 gene may be responsible for the onset of FRG. The present study provides a starting point for further investigation of the molecular pathogenesis of the SLC5A2 gene mutation in patients with FRG.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Amino Acid Sequence
  • Asian People / genetics*
  • Base Sequence
  • DNA Mutational Analysis
  • Glycosuria, Renal / diagnosis*
  • Glycosuria, Renal / genetics
  • Heterozygote
  • Humans
  • Infant
  • Male
  • Mutation, Missense
  • Sequence Alignment
  • Sodium-Glucose Transporter 2 / genetics*

Substances

  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 2